Tumour infiltrating lymphocytes as a predictive factor for the response to adjuvant endocrine therapy in early breast cancer

被引：0
|
作者：
Blok, E. [1 ]
Engels, C. [1 ]
Jongste, E. [1 ]
Dekker-Ensink, G. [1 ]
Kroep, J. [2 ]
Kuppen, P. [1 ]
Van de Velde, C. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Surg, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Med Oncol, Leiden, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30917-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1969
引用
收藏
页码：S323 / S323
页数：1
相关论文
共 50 条
  • [1] Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer
    Erik J. Blok
    Charla C. Engels
    Geeske Dekker-Ensink
    Elma Meershoek-Klein Kranenbarg
    Hein Putter
    Vincent T. H. B. M. Smit
    Gerrit-Jan Liefers
    James P. Morden
    Judith M. Bliss
    R. Charles Coombes
    John M. S. Bartlett
    Judith R. Kroep
    Cornelis J. H. van de Velde
    Peter J. K. Kuppen
    Breast Cancer Research and Treatment, 2018, 171 : 65 - 74
  • [2] Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer
    Blok, Erik J.
    Engels, Charla C.
    Dekker-Ensink, Geeske
    Kranenbarg, Elma Meershoek-Klein
    Putter, Hein
    Smit, Vincent T. H. B. M.
    Liefers, Gerrit-Jan
    Morden, James P.
    Bliss, Judith M.
    Coombes, R. Charles
    Bartlett, John M. S.
    Kroep, Judith R.
    van de Velde, Cornelis J. H.
    Kuppen, Peter J. K.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (01) : 65 - 74
  • [3] Tumour-Infiltrating Lymphocytes as a Predictor of Response in Neoadjuvant Endocrine Therapy in Breast Cancer
    Chang, N.
    Hakim, S. W.
    Kos, Z.
    Gravel, D. H.
    Arnaout, A.
    Robertson, S. J.
    MODERN PATHOLOGY, 2014, 27 : 40A - 40A
  • [4] Tumour-Infiltrating Lymphocytes as a Predictor of Response in Neoadjuvant Endocrine Therapy in Breast Cancer
    Chang, N.
    Hakim, S. W.
    Kos, Z.
    Gravel, D. H.
    Arnaout, A.
    Robertson, S. J.
    LABORATORY INVESTIGATION, 2014, 94 : 40A - 40A
  • [5] Tumour immune subtyping as a predictive biomarker for adjuvant endocrine therapy in early breast cancer
    Blok, E. J.
    Engels, C. C.
    Jongste, E.
    Dekker-Ensink, G.
    Kroep, J. R.
    Kuppen, P. J. K.
    van de Velde, C. J. H.
    CANCER RESEARCH, 2016, 76
  • [6] Tumour infiltrating lymphocytes as prognostic factor in breast cancer
    Schuler, Kathleen
    Bethmann, Daniel
    Lantzsch, Tilmann
    Uleer, Christoph
    Hanf, Volker
    Peschel, Susanne
    John, Jutta
    Poehler, Marleen
    Buchmann, Jorg
    Burrig, Karl-Friedrich
    Weigert, Edith
    Kantelhardt, Eva Johanna
    Thomssen, Christoph
    Vetter, Martina
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 35 - 35
  • [7] Predictive factor for the response to adjuvant therapy with emphasis in breast cancer
    Munster, PN
    Norton, L
    BREAST CANCER RESEARCH, 2001, 3 (06) : 361 - 364
  • [8] Predictive factor for the response to adjuvant therapy with emphasis in breast cancer
    Pamela N Munster
    Larry Norton
    Breast Cancer Research, 3
  • [9] Tumour-infiltrating CD8+lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
    Seo, A. N.
    Lee, H. J.
    Kim, E. J.
    Kim, H. J.
    Jang, M. H.
    Lee, H. E.
    Kim, Y. J.
    Kim, J. H.
    Park, S. Y.
    BRITISH JOURNAL OF CANCER, 2013, 109 (10) : 2705 - 2713
  • [10] Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
    A N Seo
    H J Lee
    E J Kim
    H J Kim
    M H Jang
    H E Lee
    Y J Kim
    J H Kim
    S Y Park
    British Journal of Cancer, 2013, 109 : 2705 - 2713
12345